These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8358391)

  • 21. Protein purification process engineering. Freeze drying: A practical overview.
    Gatlin LA; Nail SL
    Bioprocess Technol; 1994; 18():317-67. PubMed ID: 7764173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystallization of trehalose in frozen solutions and its phase behavior during drying.
    Sundaramurthi P; Patapoff TW; Suryanarayanan R
    Pharm Res; 2010 Nov; 27(11):2374-83. PubMed ID: 20811935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the crystallization propensity of carboxylic acid buffers in frozen systems--relevance to freeze-drying.
    Sundaramurthi P; Suryanarayanan R
    J Pharm Sci; 2011 Apr; 100(4):1288-93. PubMed ID: 24081466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy.
    de Waard H; De Beer T; Hinrichs WL; Vervaet C; Remon JP; Frijlink HW
    AAPS J; 2010 Dec; 12(4):569-75. PubMed ID: 20625865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.
    Abdelwahed W; Degobert G; Fessi H
    Eur J Pharm Biopharm; 2006 Jun; 63(2):87-94. PubMed ID: 16621490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of co-solutes and process variables on crystallinity and the crystal form of freeze-dried myo-inositol.
    Izutsu KI; Kusano R; Arai R; Yoshida H; Ito M; Shibata H; Sugano K; Goda Y; Terada K
    Int J Pharm; 2016 Jul; 509(1-2):368-374. PubMed ID: 27282535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Component crystallization and physical collapse during freeze-drying of L-arginine-citric acid mixtures.
    Yamaki T; Ohdate R; Nakadai E; Yoshihashi Y; Yonemochi E; Terada K; Moriyama H; Izutsu K; Yomota C; Okuda H; Kawanishi T
    Chem Pharm Bull (Tokyo); 2012; 60(9):1176-81. PubMed ID: 22976327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.
    Thakral S; Suryanarayanan R
    Pharm Res; 2015 Nov; 32(11):3722-31. PubMed ID: 26063046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization.
    Searles JA; Carpenter JF; Randolph TW
    J Pharm Sci; 2001 Jul; 90(7):872-87. PubMed ID: 11458336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a bladder instillation of the indoloquinone anticancer agent EO-9 using tert-butyl alcohol as lyophilization vehicle.
    van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L; Beijnen JH
    AAPS PharmSciTech; 2007 Aug; 8(3):E61. PubMed ID: 17915811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents.
    Wittaya-Areekul S; Nail SL
    J Pharm Sci; 1998 Apr; 87(4):491-5. PubMed ID: 9548903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous alternative to freeze drying: Manufacturing of cyclodextrin-based reconstitution powder from aqueous solution using scaled-up electrospinning.
    Vass P; Démuth B; Farkas A; Hirsch E; Szabó E; Nagy B; Andersen SK; Vigh T; Verreck G; Csontos I; Marosi G; Nagy ZK
    J Control Release; 2019 Mar; 298():120-127. PubMed ID: 30779951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry.
    Cavatur RK; Suryanarayanan R
    Pharm Dev Technol; 1998 Nov; 3(4):579-86. PubMed ID: 9834962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical state of L-histidine after freeze-drying and long-term storage.
    Osterberg T; Wadsten T
    Eur J Pharm Sci; 1999 Aug; 8(4):301-8. PubMed ID: 10425380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlling the physical form of mannitol in freeze-dried systems.
    Mehta M; Bhardwaj SP; Suryanarayanan R
    Eur J Pharm Biopharm; 2013 Oct; 85(2):207-13. PubMed ID: 23643784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimization of process of sodium aescinate lyophilized powder].
    Shi ZH; Chen LJ; Huang WF; Liu MM; Liu XP
    Zhong Yao Cai; 2014 Jul; 37(7):1265-9. PubMed ID: 25566665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.
    Kim AI; Akers MJ; Nail SL
    J Pharm Sci; 1998 Aug; 87(8):931-5. PubMed ID: 9687336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calorimetry and complementary techniques to characterize frozen and freeze-dried systems.
    Sundaramurthi P; Suryanarayanan R
    Adv Drug Deliv Rev; 2012 Apr; 64(5):384-95. PubMed ID: 22210136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.